Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR3 | P46089 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.47 |
| ▸ | MAPT | P10636 | 4/20 | 0.47 |
| ▸ | HPGD | P15428 | 4/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | KIF11 | P52732 | 1/20 | 0.46 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.43 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.42 |
| ▸ | RXRA | P19793 | 1/20 | 0.42 |
| ▸ | RXRB | P28702 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 2/20 | 0.40 |
| ▸ | RAB9A | P51151 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20022386 | 0.97 | GPR3 (0.53) | GPR3KDM4EMAPTHPGDALDH1A1 | |
| SCHEMBL20022303 | 0.97 | GPR3 (0.53) | GPR3KDM4EMAPTHPGDALDH1A1 | |
| SCHEMBL20022381 | 0.97 | GPR3 (0.53) | GPR3KDM4EMAPTHPGDALDH1A1 | |
| SCHEMBL20022351 | 0.97 | GPR3 (0.53) | GPR3KDM4EMAPTHPGDALDH1A1 | |
| SCHEMBL13181224 | 0.94 | KIF11 (0.50) | GPR3KDM4EMAPTHPGDALDH1A1 | |
| SCHEMBL20022349 | 0.87 | GPR3 (0.46) | GPR3KDM4EMAPTHPGDALDH1A1 | |
| SCHEMBL8932254 | 0.86 | GPR3 (0.48) | GPR3KDM4EMAPTHPGDALDH1A1 | |
| SCHEMBL20022354 | 0.86 | GPR3 (0.42) | GPR3KDM4EMAPTHPGDALDH1A1 | |
| SCHEMBL12419782 | 0.85 | GPR3 (0.64) | GPR3KDM4EMAPTHPGDALDH1A1 | |
| SCHEMBL15747209 | 0.84 | PSEN1 (0.48) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8003807-B2 | organic thin film transistor with a semiconductor layer including the small molecule having didodecylindolo[3,2-b]carbazole groups | XEROX CORPORATION (US) | 2011-08-23 | — | — | US | disclosed |
| US-7868186-B2 | Device containing polymer having indolocarbazole- repeat unit and divalent linkage | XEROX CORPORATION (US) | 2011-01-11 | — | — | US | disclosed |
| US-7829727-B2 | Device containing compound having indolocarbazole moiety and divalent linkage | XEROX CORPORATION (US) | 2010-11-09 | — | — | US | disclosed |
| US-20100230670-A1 | DEVICE CONTAINING COMPOUND HAVING INDOLOCARBAZOLE MOIETY AND DIVALENT LINKAGE | XEROX CORPORATION (US) | 2010-09-16 | — | — | US | disclosed |
| US-20090114909-A1 | organic thin film transistor with a semiconductor layer including the polymer of 2,8-Bis(2-thienyl)-5,11-didodecylindolo[3,2-b]carbazole; organic photovoltaics | XEROX CORPORATION (US) | 2009-05-07 | — | — | US | disclosed |
| US-7528261-B2 | Small molecule compound having indolocarbazole moiety and divalent linkage | XEROX CORPORATION (US) | 2009-05-05 | — | — | US | disclosed |
| US-20080207917-A1 | POLYMER HAVING INDOLOCARBAZOLE MOIETY AND DIVALENT LINKAGE | XEROX CORPORATION (US) | 2008-08-28 | — | — | US | disclosed |
| US-20080103314-A1 | SMALL MOLECULE COMPOUND HAVING INDOLOCARBAZOLE MOIETY AND DIVALENT LINKAGE | XEROX CORPORATION (US) | 2008-05-01 | — | — | US | disclosed |
| US-20070112167-A1 | Device containing compound having indolocarbazole moiety and divalent linkage | XEROX CORPORATION | 2007-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080103314-A1 | SMALL MOLECULE COMPOUND HAVING INDOLOCARBAZOLE MOIETY AND DIVALENT LINKAGE | SLC43A1, SLC7A5, KCNN2 | GPR3 1530/4885KDM4E 4093/4885MAPT 153/4885 |
| US-20100230670-A1 | DEVICE CONTAINING COMPOUND HAVING INDOLOCARBAZOLE MOIETY AND DIVALENT LINKAGE | BRD4, BICRA, INMT | GPR3 2016/4885KDM4E 3154/4885MAPT 955/4885 |
| US-20080207917-A1 | POLYMER HAVING INDOLOCARBAZOLE MOIETY AND DIVALENT LINKAGE | SGTA, MTCL3, SMC3 | GPR3 2775/4885KDM4E 4060/4885MAPT 196/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.